RxDoctor Payments Data

Narendra Yallanki

Pediatric Gastroenterology · Corpus Christi, TXNPI 1992146419

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,949 of the $4,015 with a category attached, or 73.4%. 19 manufacturers reported payments, led by Sanofi at 38.4% of the total. Reporting peaked in 2023 at $2,054 and has fallen 85.6% since, to $295 in 2024.

$4,015in general payments, 2019–2025

Across 123 payments — averaging $32.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$2K
  • AbbVie$727
  • QOL Medical, LLC$506
  • Nestle Healthcare Nutrition Inc.$273
  • Takeda Pharmaceuticals U.S.A., Inc.$204
  • Amgen$198
  • plus $564 from 13 others

What the payments were for

  • Consulting fees$1,06226%
  • Food & beverage$2,94973%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,015 in reported general payments places this provider in the 80th percentile of 159 pediatric gastroenterology providers in Texas.

See all pediatric gastroenterology providers in Texas

Other pediatric gastroenterology in Corpus Christi

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →